Literature DB >> 24566725

Is there a need for bacterial endocarditis prophylaxis in patients undergoing gastrointestinal endoscopy?

Salvatore Patanè1.   

Abstract

Heart valve repair or replacement is a serious problem. Patients can benefit from an open dialogue between both cardiologists and gastroenterologists for the optimal effective patients care. The focused update on infective endocarditis of the American College of Cardiology/American Heart Association 2008 (ACC/AHA guidelines) and guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009) of the European Society of Cardiology (ESC guidelines) describe prophylaxis against infective endocarditis (IE) as not recommended for gastroscopy and colonoscopy in the absence of active infection but increasing evidence suggests that the role of IE antibiotic prophylaxis remains a dark side of the cardio-oncology prevention. New evidences concerning infective endocarditis due to Streptococcus bovis, Streptococcus agalactiae, Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, and new findings indicate that there is a need for bacterial endocarditis prophylaxis in patients undergoing gastrointestinal endoscopy especially in elderly patients and in cancer and immunocompromised patients, to avoid serious consequences.

Entities:  

Mesh:

Year:  2014        PMID: 24566725     DOI: 10.1007/s12265-014-9553-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  35 in total

1.  ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Rick A Nishimura; Blase A Carabello; David P Faxon; Michael D Freed; Bruce W Lytle; Patrick T O'Gara; Robert A O'Rourke; Pravin M Shah
Journal:  J Am Coll Cardiol       Date:  2008-08-19       Impact factor: 24.094

2.  Antibiotic prophylaxis for GI endoscopy.

Authors:  Subhas Banerjee; Bo Shen; Todd H Baron; Douglas B Nelson; Michelle A Anderson; Brooks D Cash; Jason A Dominitz; S Ian Gan; M Edwyn Harrison; Steven O Ikenberry; Sanjay B Jagannath; David Lichtenstein; Robert D Fanelli; Ken Lee; Trina van Guilder; Leslie E Stewart
Journal:  Gastrointest Endosc       Date:  2008-03-28       Impact factor: 9.427

3.  Robotic mitral valve repair in infective endocarditis.

Authors:  Nai-Hsin Chi; Chi-Hsiang Huang; Shu-Chien Huang; Hsi-Yu Yu; Yih-Sharng Chen; Shoei-Shen Wang; I-Hui Wu
Journal:  J Thorac Dis       Date:  2014-01       Impact factor: 2.895

4.  Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures?

Authors:  Salvatore Patanè
Journal:  J Cardiovasc Transl Res       Date:  2014-02-25       Impact factor: 4.132

Review 5.  Using imaging to guide patient selection and performance of catheter-based mitral valve repair for mitral regurgitation.

Authors:  D Scott Lim
Journal:  J Cardiovasc Transl Res       Date:  2013-09-21       Impact factor: 4.132

Review 6.  Clinical impact of genetically determined platelet reactivity.

Authors:  Marc Laine; Sébastien Arméro; Michaël Peyrol; Pascal Sbragia; Franck Thuny; Franck Paganelli; Laurent Bonello
Journal:  J Cardiovasc Transl Res       Date:  2012-11-13       Impact factor: 4.132

Review 7.  Infective endocarditis: the European viewpoint.

Authors:  Pilar Tornos; Teresa Gonzalez-Alujas; Frank Thuny; Gilbert Habib
Journal:  Curr Probl Cardiol       Date:  2011-05       Impact factor: 5.200

Review 8.  Isolation of Streptococcus bovis from apheresis platelets of asymptomatic donor warranted colonoscopy investigation: case report and literature review.

Authors:  Chun-Yu Lin; Shih-Bin Tseng; Po-Liang Lu; Tun-Chieh Chen; Wei-Ru Lin; Yen-Hsu Chen; Kuo-Sin Lin
Journal:  Transfusion       Date:  2011-03-10       Impact factor: 3.157

9.  Streptococcus agalactiae sepsis after transfusion of a plateletpheresis concentrate: benefit of donor evaluation.

Authors:  Wesley T Stevens; Charles D Bolan; Jaime M Oblitas; David F Stroncek; John E Bennett; Susan F Leitman
Journal:  Transfusion       Date:  2006-04       Impact factor: 3.157

10.  Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants.

Authors:  Eliane Saori Otaguiri; Ana Elisa Belotto Morguette; Eliandro Reis Tavares; Pollyanna Myrella Capela dos Santos; Alexandre Tadachi Morey; Juscélio Donizete Cardoso; Márcia Regina Eches Perugini; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  BMC Microbiol       Date:  2013-12-21       Impact factor: 3.605

View more
  2 in total

Review 1.  Insights into cardio-oncology: Polypharmacology of quinazoline-based α1-adrenoceptor antagonists.

Authors:  Salvatore Patanè
Journal:  World J Cardiol       Date:  2015-05-26

Review 2.  Malignancy and Endocarditis: Divulging Into the Intertwined Association.

Authors:  Lakshmi Sree Pugalenthi; Mahlika Ahmad; Sanjana Reddy; Zineb Barkhane; Jalal Elmadi; Lakshmi Satish Kumar
Journal:  Cureus       Date:  2022-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.